Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity

Abstract

Methylphenidate use reduced and sustained BMI change in children with hypothalamic obesity. Stimulant therapy is an effective first-line agent for treatment of hypothalamic obesity.